MAY 23, 2019 11:29 PM PDT

Rapamycin and Anti-Aging

WRITTEN BY: Nouran Amin

Rapamycin was considered a wonder drug upon its discovery three decades ago when it was isolated from soil bacteria. It works as an immuno-suppressor in a variety of ways and has been to reduce immune responses in patients who received organ transplants. Now, rapamycin is garnering popularity again for its potential role in cancer therapy, neuroprotection, and most notably in anti-aging therapies.

Rapamycin inhibits cell growth by targeting mTOR--the master regulator of cell growth in our cells. The targeting of mTOR leads to autophagy, a process by which cellular lysosomes eradicate misfolded proteins and damaged organelles.

"The main function of the lysosome is to maintain the healthy state of the cell because it degrades the harmful stuff within the cell," said Xiaoli Zhang, a postdoctoral researcher in the University of Michigan Department of Molecular, Cellular and Developmental Biology. "During stress conditions, autophagy can lead to the cell survival by degrading dysfunctional components and providing the building blocks of cells, such as amino acids and lipids."

Now, new research points to more than one cellular pathway being targeted by the rapamycin such pathway involves a calcium ion channel on the lysosomal membrane known as TRPML1 and is critical in regulating lysosomal function. "Without this channel, you get neurodegeneration," said Haoxing Xu, principal investigator of the study. "If you stimulate the channel, it's anti-neurodegeneration."

Findings were published in PLOS Biology.

"We think lysosomal TRPML1 may contribute significantly to the neuroprotective and anti-aging effects of rapamycin," says lead author Wei Chen, who worked on investigating TRPML1 by using a unique technique called a lysosome patch clamp. "The identification of a new target of rapamycin offers an insight in developing the next generation of rapamycin, which will have a more specific effect on neurodegenerative disease."

Source: Medical Xpress

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 25, 2019
Drug Discovery & Development
NOV 25, 2019
Discovery of mechanism behind Alexander disease may lead to enhanced drug development
Researchers have long known that the cause behind Alexander disease is a genetic culprit—mainly a mutation leading to the production of a defective p...
DEC 05, 2019
Health & Medicine
DEC 05, 2019
Once-a-Month Contraceptive Pill Closer to Reality
While a variety of contraceptive options exist, each has its pros and cons. As many women understand, one of the major drawbacks of the daily birth control...
DEC 12, 2019
Drug Discovery & Development
DEC 12, 2019
Probiotics Treat Alcohol-Induced Liver Injury
Alcoholic liver injury is caused by overconsumption of alcohol, something that can lead to serious diseases such as liver steatosis, liver cirrhosis and li...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
Novel Drug for Treating Insomnia
The U.S. Food and Drug Administration (FDA) has approved DAYVIGO™ (lemborexant) in 5 mg and 10 mg for the treatment of insomnia among adult patients ...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
Loading Comments...